ALLAN MARK WACHTER
Medical Practice in Tempe, AZ
License number
Pennsylvania MD037669E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Tempe, AZ 85284
Pennsylvania
Pennsylvania
Personal information
See more information about ALLAN MARK WACHTER at radaris.comName
Address
Phone
8547 S Dorsey Ln, Tempe, AZ 85284
9822 S Grandview Dr, Tempe, AZ 85284
12020 Warner Elliot Loop, Phoenix, AZ 85044
8547 Dorsey Ln, Tempe, AZ 85284
9822 Grandview Dr, Tempe, AZ 85284
Professional information
Treatment Of Psoriasis
US Patent:
5190917, Mar 2, 1993
Filed:
Apr 11, 1991
Appl. No.:
7/683620
Inventors:
John Lezdey - Cherry Hill NJ
Allan J. Wachter - Tempe AZ
Allan J. Wachter - Tempe AZ
International Classification:
A61K 3764, A61K 3157
US Classification:
514 12
Abstract:
A method for the prophylaxis or direct treatment of dermatitis including psoriasis which comprises administering to the site of the disease an effective amount of a corticosteroid and a company which inhibits mast cells or binds with their mediators.
Topical .Alpha.-1-Antitrypsin, Non-Aqueous Lipid Miscible, Benzalkonium Chloride Compositions For Treating Skin
US Patent:
5346886, Sep 13, 1994
Filed:
Nov 15, 1993
Appl. No.:
8/151980
Inventors:
John Lezdey - Cherry Hill NJ
Allan Wachter - Tempe AZ
Allan Wachter - Tempe AZ
International Classification:
A61K 3710, A61K 31135
US Classification:
514 8
Abstract:
The invention provides a pharmaceutical composition for the treatment of a mammal having a skin disease. The composition contains a serine protease inhibitor and an effective amount of a cationic quaternary ammonium salt at a concentration below the critical micelle concentration for increasing the penetration of the inhibitor in the skin. Additionally, these may be included an ethoxylated nonylphenol.
Intrapulmonary Delivery Device
US Patent:
6085742, Jul 11, 2000
Filed:
Apr 17, 1998
Appl. No.:
9/062033
Inventors:
Allan Wachter - Tempe AZ
Stuart Lindsay - Tempe AZ
Stuart Lindsay - Tempe AZ
Assignee:
Aeromax Technologies, Inc. - Phoenix AZ
International Classification:
A61M 1100
US Classification:
12820023
Abstract:
The invention provides an inhalation device for administering a medicament within a prescribed dosage range to avoid over or under administration. The device contains in the mouthpiece or nozzle a channel which follows the Poiseuille equation and provides a flow rate of the fluid containing the medicament at a flow rate of between 0. 5 and 3. 0 l/s.
Dermatological And Cosmetic Compositions Containing Marama Bean Extract
US Patent:
5869063, Feb 9, 1999
Filed:
Jun 29, 1998
Appl. No.:
/107565
Inventors:
John Lezdey - Voorhees NJ
Allan Wachter - Tempe AZ
Allan Wachter - Tempe AZ
Assignee:
Protease Sciences, Inc. - Voorhees NJ
International Classification:
A61K 706, A61K 3578
US Classification:
4241951
Abstract:
Compositions and methods are provided for treating the skin especially where it is placed in an environment which can cause injury or inflammation to the skin. The compositions contain an effective amount of the extract from marama beans.
Treatment Of Pulmonary Disease With Protease Inhibitors
US Patent:
5780440, Jul 14, 1998
Filed:
Oct 11, 1996
Appl. No.:
8/731255
Inventors:
John Lezdey - Collingswood NJ
Allan Wachter - Tempe AZ
Barry Starcher - Bullard TX
Allan Wachter - Tempe AZ
Barry Starcher - Bullard TX
Assignee:
Protease Sciences Inc. - Voorhees NJ
International Classification:
A61K 3800, A61K 3846
US Classification:
514 21
Abstract:
The invention relates to methods and compositions for the prevention or treatment of patients suffering from respiratory distress syndrome and/or sepsis syndrome by administering directly into the lungs small or nicrocrystalline particles or droplets of at least one protease inhibitor alone or with an oxygen metabolite scavenger. The method can also include the treatment in combination with the monitoring of the urine desmosine level of the patients and the use of DNase.
Method For Deactivating Viruses In Blood Component Containers
US Patent:
5376633, Dec 27, 1994
Filed:
Sep 15, 1993
Appl. No.:
8/122204
Inventors:
John Lezdey - Cherry Hill NJ
Allan Wachter - Tempe AZ
Allan Wachter - Tempe AZ
International Classification:
A61K 3710, A61K 37547
US Classification:
514 8
Abstract:
The present invention provides a method for inhibiting viral proliferation by preventing or inhibiting viral replication or killing the viruses on contact. Viral replication is prevented or inhibited through the use of serine protease inhibitors, their analogs, salts, conjugates or derivatives.
Treatment Of Mast Cell Tumors
US Patent:
5492889, Feb 20, 1996
Filed:
Oct 17, 1994
Appl. No.:
8/331022
Inventors:
John Lezdey - Cherry Hill NJ
Allan Wachter - Tempe AZ
Allan Wachter - Tempe AZ
International Classification:
A61K 3816
US Classification:
514 8
Abstract:
There is provided a method for treating tumors in mammals by the administration of alpha 1-antitrypsin alone or in combination with other protease inhibitors.
Treatment Of Inflammation
US Patent:
5217951, Jun 8, 1993
Filed:
Oct 18, 1991
Appl. No.:
7/781003
Inventors:
John Lezdey - Cherry Hill NJ
Allan J. Wachter - Tempe AZ
Allan J. Wachter - Tempe AZ
International Classification:
A61K 3764
US Classification:
514 8
Abstract:
A method for the prophylaxis or direct treatment of non-bronchial mast cell implicated diseases or injuries in a patient which comprises administering to the site of the disease or injury an effective amount of at least one serine protease inhibitor, its salts, derivatives or analogs which bind with the mast cells or their mediators.
Antiviral Compositions And Method Of Use
US Patent:
5532215, Jul 2, 1996
Filed:
Oct 3, 1994
Appl. No.:
8/322293
Inventors:
John Lezdey - Cherry Hill NJ
Allan Wachter - Tempe AZ
Allan Wachter - Tempe AZ
International Classification:
A61K 3816, A61K 3848
US Classification:
514 8
Abstract:
The present invention provides a method for inhibiting viral proliferation by preventing or inhibiting viral replication or killing the viruses on contact. Viral replication is prevented or inhibited through the use of serine protease inhibitors, their analogs, salts, conjugates or derivatives.
Method Of Treatment
US Patent:
6124257, Sep 26, 2000
Filed:
Nov 30, 1998
Appl. No.:
9/201608
Inventors:
John Lezdey - Voorhees NJ
Allan Wachter - Tempe AZ
Allan Wachter - Tempe AZ
International Classification:
A61K 3800, A61K 3828, A61K 3848
US Classification:
514 2
Abstract:
Compositions and methods of treating disease and injuries wherein by sequentially or co-administering pulmonarily a polypeptide effective for the treatment of the injury or disease and a protease inhibitor capable of binding with elastase or cathepsin G.